Deepak Chem Tech raises Rs 40 crore via 9 percent convertible preference shares

Fund Raising View source PDF Explain this filing

DEEPAKNTR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹1771.00

prior close

₹1765.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-1.3% vs market

Specialty Chemicals peers, median of 85sector+0.0%-0.8% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Smallcap 250 and 0.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+0.8

15m

+0.7

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.5-1.3+0.0-0.8

Next day

+0.1+1.2-1.2+1.0-1.0

-0.4+1.0-1.4+1.0-1.4

-0.7+0.8-1.6+0.6-1.4

-1.3+1.5-2.8-0.2-1.1

-1.2+1.6-2.7+0.0-1.2

-1.8+2.0-3.7-0.6-1.2

15d

-2.4+0.3-2.7-4.0+1.6

-3.6-0.8-2.7-5.3+1.7

-5.0-3.0-2.0-8.8+3.8

-9.3-8.7-0.6-16.8+7.5

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Deepak Chem Tech, a wholly owned subsidiary of Deepak Nitrite, issued 40 lakh 9 percent optionally convertible redeemable preference shares to fellow subsidiary Deepak Phenotics. The shares were issued at face value for Rs 40 crore in cash. The funds will strengthen Deepak Chem Tech's capital base and support projects for its Gujarat fluorination plant, which had FY25 turnover of Rs 9.43 crore. Deepak Nitrite's effective ownership is unchanged.

Likely market impact

Supports subsidiary projects with no ownership change. Returns depend on project execution and the cost of the 9 percent preference funding.